Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523168 · ClinicalTrials.gov registry record · NA
Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction
A NA study of Coronary Microvascular Dysfunction, sponsored by Amir Lerman.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04523168 is a NA study of Coronary Microvascular Dysfunction that has completed, run by Amir Lerman. The registered enrollment target is 30 participants, below the 268-participant average among 7 other Coronary Microvascular Dysfunction trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04523168, a NA study of Coronary Microvascular Dysfunction, has completed, sponsored by Amir Lerman.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to evaluate the role of a novel implantable device, called The Neovasc Reducer™ System, in improving microvascular function, symptoms and quality of life in symptomatic patients with coronary microvascular dysfunction.
Conditions Studied
Interventions
- DEVICE The Neovasc Reducer™ System
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2023-07-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04523168
The ClinicalTrials.gov registry entry for NCT04523168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 7 other Coronary Microvascular Dysfunction trials with a reported enrollment target (89% lower). The listed sponsor is Amir Lerman, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Microvascular Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which The Neovasc Reducer™ System is the first listed.
NCT04523168 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04523168 about?
NCT04523168 is a clinical study titled "Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction". This study is being done to evaluate the role of a novel implantable device, called The Neovasc Reducer™ System, in improving microvascular function, symptoms and quality of life in symptomatic patients with coronary microvascular dysfunction.
What is the current status of trial NCT04523168?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-06-28. Estimated completion is 2023-07-28.
What conditions does trial NCT04523168 study?
This clinical trial studies the following conditions: Coronary Microvascular Dysfunction.
What interventions are being tested in trial NCT04523168?
The interventions under investigation include: The Neovasc Reducer™ System (DEVICE).
Who is sponsoring clinical trial NCT04523168?
This trial is sponsored by Amir Lerman, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04523168 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Microvascular Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Coronary Vascular Health in Women
RECRUITING · Phase 2
-
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
RECRUITING
-
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
RECRUITING
-
Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution
RECRUITING
-
Coronary Microvascular Disease (CMD) Registry
RECRUITING
-
The DISCOVER INOCA Prospective Multi-center Registry
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.